2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
January 06, 2017
Codexis to Offer High-Performance Enzymes for Diagnostics Markets
REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will offer high-performance enzymes for customers using next generation sequencing (NGS) and polymerase chain reaction (PCR/qPCR) for in vitro molecular diagnostic applications.  Codexis’ first proprietary enzyme for this market will target improved library preparation for NGS users, and is expected to be available in beta-test format by the second quart... 

Sign up for E-mail Alerts

You may automatically receive Codexis, Inc. information by e-mail

Enter your e-mail address here:
Print Page Print Page | E-mail Page E-mail Page |

Share Page

| Financial Tear Sheet Tear Sheet
You are now leaving this website. If you would like to continue, click Continue.